Contact this trialFirst, we need to learn more about you.
Sodium Glucose Co-Transporter-2 Inhibitor
SGLT2 Inhibitor + GLP-1 Agonist for Kidney Transplant Recipients
Recruiting1 awardPhase 2
Toronto, Ontario
This trial looks at the effects of a combination of two drugs on 20 kidney transplant recipients, with and without type 2 diabetes.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.